These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37430223)

  • 1. Influencing factors of low vision 2 years after vitrectomy for proliferative diabetic retinopathy: an observational study.
    Wang S; Liu Y; Du Y; Bao H; Zhu J; Liu X
    BMC Ophthalmol; 2023 Jul; 23(1):309. PubMed ID: 37430223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy.
    Dervenis P; Dervenis N; Smith JM; Steel DH
    Cochrane Database Syst Rev; 2023 May; 5(5):CD008214. PubMed ID: 37260074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Smith JM; Steel DH
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of visual outcome after pars plana vitrectomy secondary to proliferative diabetic retinopathy.
    Nisic F; Gadzo AP; Fajkic A; Nisic A; Miokovic AP; Damjanovic G; Begic E; Beslic N; Lepara O
    Rom J Ophthalmol; 2023; 67(3):283-288. PubMed ID: 37876512
    [No Abstract]   [Full Text] [Related]  

  • 5. Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy.
    Douglas MJ; Scott IU; Flynn HW
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):270-8. PubMed ID: 12875454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
    Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
    J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pars plana vitrectomy, phacoemulsification and intraocular lens implantation for the management of cataract and proliferative diabetic retinopathy: comparison of a combined versus two-step surgical approach].
    Rivas-Aguiño P; García-Amaris RA; Berrocal MH; Sánchez JG; Rivas A; Arévalo JF
    Arch Soc Esp Oftalmol; 2009 Jan; 84(1):31-8. PubMed ID: 19173136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
    Yamamoto T; Hitani K; Tsukahara I; Yamamoto S; Kawasaki R; Yamashita H; Takeuchi S
    Am J Ophthalmol; 2003 Jan; 135(1):14-9. PubMed ID: 12504691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.
    Pei M; Zhao X; Wan G
    Ophthalmic Res; 2023; 66(1):777-790. PubMed ID: 36972566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Surgical Outcomes of Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy.
    Alshaikhsalama AM; Thompson KN; Patrick H; Lee J; Voor TA; Wang AL
    Ophthalmol Retina; 2024 Aug; 8(8):823-831. PubMed ID: 38447921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical strategy and outcome in patients with bilateral proliferative diabetic retinopathy.
    Jiang JH; Wu RH; Ren MX; Lin K; Lin W; Hu XT; Chen F; Zhao ZQ; Ge LN; Lin Z
    Int Ophthalmol; 2023 Dec; 43(12):4921-4931. PubMed ID: 37837486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis value of Chinese Ocular Fundus Diseases Society classification for proliferative diabetic retinopathy on postoperative visual acuity after pars plana vitrectomy in type 2 diabetes.
    Lin TZ; Kong Y; Shi C; Eric Pazo E; Dai GZ; Wu XW; Xu L; Shen LJ
    Int J Ophthalmol; 2022; 15(10):1627-1633. PubMed ID: 36262848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients.
    Liao M; Wang X; Yu J; Meng X; Liu Y; Dong X; Li J; Brant R; Huang B; Yan H
    BMC Ophthalmol; 2020 Oct; 20(1):416. PubMed ID: 33076873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Minimally invasive vitrectomy for the treatment of severe proliferative diabetic retinopathy].
    Zheng CZ; Ren XJ; Ke YF; Wen DJ; Li XR
    Zhonghua Yan Ke Za Zhi; 2021 Jun; 57(6):440-446. PubMed ID: 34098693
    [No Abstract]   [Full Text] [Related]  

  • 15. Vision-related quality of life and visual function following vitrectomy for proliferative diabetic retinopathy.
    Okamoto F; Okamoto Y; Fukuda S; Hiraoka T; Oshika T
    Am J Ophthalmol; 2008 Jun; 145(6):1031-1036. PubMed ID: 18400203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal impairment may indicate postoperative low vision in young patients with proliferative diabetic retinopathy undergoing vitrectomy.
    Zheng X; Feng L; Xing C; Wang J; Zhao W; Zhang F
    Front Endocrinol (Lausanne); 2023; 14():1321226. PubMed ID: 38274226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice.
    Gupta B; Wong R; Sivaprasad S; Williamson TH
    Eye (Lond); 2012 Apr; 26(4):576-82. PubMed ID: 22241020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended silicone oil tamponade in primary vitrectomy for complex retinal detachment in proliferative diabetic retinopathy: a long-term follow-up study.
    Shen YD; Yang CM
    Eur J Ophthalmol; 2007; 17(6):954-60. PubMed ID: 18050123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
    Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
    Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of vitreous surgery for proliferative diabetic retinopathy.
    Sima P; Zoran T
    Doc Ophthalmol; 1994; 87(3):223-32. PubMed ID: 7835192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.